Fundz

Rgenta Therapeutics reported raising $41.9 Million in an initial SEC Form D filing, from an offering of $130 Million

PRIVATENov 03, 2026$41.9M of $130.1M raised

Amount Raised

$41.9 Million

$41.9 Million sold, per SEC Form D (first sale Oct 19, 2026)

Round Type

Venture

CambridgeOtherBiotechnologyHealth CareVenture Capital

Who to call at Rgenta Therapeutics, Inc., and when

A new round usually means Rgenta Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rgenta Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rgenta Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rgenta Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rgenta Therapeutics, Inc.

Location

700 Main Street

Cambridge, Maryland, United States

About

Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs. Our lead programs and unique approach are unlocking the therapeutic potential of historically undruggable targets in human diseases. Learn more at http://www.rgentatx.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rgenta Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Rgenta Therapeutics, Inc.'s next move

See what Strategic adds

Rgenta Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.